Radiotherapy with or without androgen deprivation in the treatment of localized adenocarcinoma of the prostate

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 21, Issue 1, 1998, Pages 1-5

  Arcangeli, Giorgio ^a,b,f   Saracino, Biancamaria ^b   Micheli, Adriana ^a   D'Angelo, Luciano ^a   Pansadoro, Vito ^c   Cruciani, Enrico ^d   Marchetti, Paolo ^e  

^a SANTA MARIA GORETTI HOSPITAL   (Italy)

^b Radiotherapy Centre   (Italy)

^c SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

^d Urology Division   (Italy)

^e UNIVERSITY OF L'AQUILA   (Italy)

^f REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Adjuvant androgen deprivation; Early endocrine manipulation; Radiotherapy of prostate cancer

Indexed keywords

ANDROGEN; ESTROGEN; GONADORELIN AGONIST;

ADJUVANT THERAPY; ADULT; AGED; ANDROGEN BLOOD LEVEL; ARTICLE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; DOSE RESPONSE; FOLLOW UP; HORMONE DEFICIENCY; HUMAN; IRRADIATION; MAJOR CLINICAL STUDY; NEEDLE BIOPSY; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT PLANNING;

ADENOCARCINOMA; ADULT; AGED; COMBINED MODALITY THERAPY; ESTROGENS; HORMONES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; ORCHIECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RECEPTORS, ANDROGEN; RECEPTORS, LHRH; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0031892831     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199802000-00001     Document Type: Article

References (26)

1. Aubel OGJM, Hoekstra WJ, Schroder FH. Early orchiectomy for patients with stage D1 prostatic carcinoma. J Urol 1985; 134:292-4.
2. Barnes R, Hadley H, Axford P, et al. Conservative treatment of early carcinoma of prostate. Comparison of patients less than seventy with those over seventy years of age. Urology 1979; 14:359-62.
3. Gee WF, Cole JR. Symptomatic stage C carcinoma of prostate: traditional therapy. Urology 1980;25:335-7.
4. Myers RP, Zincke H, Fleming TR, et al. Hormonal treatment at time of radical retropubic prostatectomy for stage D1 prostate cancer. J Urol 1983;130:99-101.
5. Harisiadis L, Veenema RJ, Seyszyn JJ, et al. Carcinoma of the prostate: treatment with external radiotherapy. Cancer 1978; 41:2131-42.
6. Neglia WJ, Hussey DH, Johnson DE. Megavoltage radiation therapy for carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1977;2:873-82.
7. Ray GR, Cassady JR, Bagshaw MA. Definitive radiation therapy of carcinoma of the prostate. Radiology 1973;106:407-18.
8. Rosen EM, Cassady JR, Connoly J, et al. Radiotherapy for localized prostate carcinoma. Int J Radiat Oncol Biol Phys 1984;10:2201-10.
9. van der Werf-Messing B, Sourek-Zikova V, Blonk DI. Localized advanced carcinoma of the prostate: radiation therapy versus hormonal therapy. Int J Radiat Oncol Biol Phys 1976;1:1043-8.
10. Pilepich MV, Krall JM, Sause WT, et al. Prognostic factors in carcinoma of the prostate - analysis of RTOG study 75-06. Int J Radiat Oncol Biol Phys 1987;13:339-49.
11. Green N, Bodner H, Broth E, et al. Improved control of bulky prostate carcinoma with sequential estrogen and radiation therapy Int J Radiat Oncol Biol Phys 1984;10:971-6.
12. Mukamed E, Servadio C, Lurie H. Combined external radiotherapy and hormonal therapy for localized carcinoma of the prostate. Prostate 1983;4:283-7.
13. Perez CA, Garcia D, Simpson JR, et al. Factors influencing outcome of definitive radiotherapy for localized carcinoma of the prostate. Radiother Oncol 1989;16:1-21.
14. Schild SE, Wong WW, Grado GL, et al. The results of radical retropubic prostatectomy and ajuvant therapy for pathologic stage C prostate cancer. Int J Radiat Oncol Biol Phys 1996; 34:535-41.
15. Poppel HV, De Ridder D, Elgamel AA, et al. Neoadjuvant hormonal therapy before radical prostatectomy decreases the number of positive surgical margins in stage T2 prostate cancer: interim results of a prospective randomized trial. J Urol 1995;154:429-34.
16. Arcangeli G, Micheli A, Arcangeli GC, et al. Definitive radiation therapy for localized prostatic adenocarcinoma. Int J Radiat Oncol Biol Phys 1991;20:439-46.
17. Arcangeli G, Micheli A, Verna L, et al. Prognostic impact of transurethral resection on patients irradiated for localized prostate cancer. Radiother Oncol 1995;35:123-8.
18. Kaplan El, Meier P. Non-parametric estimation from incomplete observation. Journal of the American Statistical Association 1958;53:457-81.
19. Kalbfleisch JD, Prentice RL, eds. The statistical analysis of failure time data. New York: Wiley, 1980.
20. Akakura K, Bruchovsky N, Goldenberg SL, et al. Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen. Cancer 1993;71:2762-90.
21. Zagars GK, Johnson DE, von Eschenbach AC, et al. Adjuvant estrogen following radiation therapy for stage C adenocarcinoma of the prostate: long-term results of a prospective randomized study. Int J Radiat Oncol Biol Phys 1988;14:1085-91.
22. Pilepich MV, Sause WT, Shipley WU, et al. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. Urology 1995;45:616-23.
23. Byar DP. The Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate. Cancer 1973;32:1126-30.
24. Byar DP. The Veterans Adminitration Cooperative Urological Research Group's studies of conservative treatment. Scand J Urol 1980;55(suppl):99-102.
25. Byar DP. The Veterans Administration Cooperative Urological Research Group's studies of post-prostatectomy survival. Scand J Urol 1980;55(suppl):113-6.
26. Byar DP Corle DK. The Veterans Administration Cooperative Research Group's randomized trial of radical prostatectomy for stages I and II prostate cancer. Urology 1981;17:7-11.